Medical specialists from Netherlands tagged as investigators in clinical trials studying Myeloid Leukemia

Total 31 results

A. van Rhenen
Seen in:
- Utrecht, NL-Utrecht-UMCUTRECHT
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Anna van Rhenen, MD
Seen in:
- Other, Utrecht, University Medical Center (UMC) Utrecht
Trials:
- NCT04227847 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome
B.J. Biemond
Seen in:
- Amsterdam, NL-Amsterdam-AMC
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Bianca Goemans, MD, PhD
Seen in:
- Utrecht, Princess Maxima Center for Pediatric Oncology
Trials:
- NCT05994690 (Principal Investigator)
- NCT06262438 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia in Children
Birgitta VERSLUYS, MD
Seen in:
- Groningen, University Medical Centre Groningen
- Utrecht, Princess Maxima Center for Pediatric Oncology
Trials:
- NCT01281735 (Principal Investigator)
- NCT05477589 (Principal Investigator)
Conditions:
D. van Lammeren-Venema
Seen in:
- Den Haag, NL-Den Haag-HAGA
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
E. Ammatuna
Seen in:
- Groningen, NL-Groningen-UMCG
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
G. van der Sluis
Seen in:
- Zwolle, NL-Zwolle-ISALA
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
H.A.M. Sinnige
Seen in:
- Den Bosch, NL-Den Bosch-JBZ
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Hans Pruijt
Seen in:
- s' Hertogenbosch, Jeroen Bosch Ziekenhuis
Trials:
- NCT00838240 (Principal Investigator)
Conditions:
- Myelodysplastic Syndromes;
- Leukemia
Hendrik J Veelken
Seen in:
- Other, Leiden, Leids Universitair Medisch Centrum ( LUMC)
Trials:
- NCT04227847 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome
J.C. Regelink
Seen in:
- Amersfoort, NL-Amersfoort-MEANDERMC
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
J.H. Veelken
Seen in:
- Leiden, NL-Leiden-LUMC
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Janine van Elssen
Seen in:
- Maastricht, NL-Maastricht-MUMC
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
L.W. Tick
Seen in:
- Eindhoven, NL-Eindhoven-MAXIMAMC
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
M. Cuijpers
Seen in:
- Arnhem, NL-Arnhem-RIJNSTATE
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
M. Donker
Seen in:
- Amsterdam, NL-Amsterdam-VUMC
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
M. Hoogendoorn
Seen in:
- Leeuwarden, NL-Leeuwarden-MCL
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
M. van Söhne
Seen in:
- Nieuwegein, NL-Nieuwegein-ANTONIUS
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
M.C.J.C. Legdeur
Seen in:
- Enschede, NL-Enschede-MST
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
M.H.G.P. Raaijmakers
Seen in:
- Rotterdam, NL-Rotterdam-ERASMUSMC
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Maaike LUESINK, MD
Seen in:
- Utrecht, Dutch Childhood Oncology Group, Princess Maxima Center for pediatric oncology
Trials:
- NCT01281735 (Principal Investigator)
Conditions:
- Chronic Myeloid Leukemia
Michael Zwaan
Seen in:
- Utrecht, Princess Maxima Center for Pediatric Oncology
Trials:
- NCT04065399 (Principal Investigator)
Conditions:
Mojca Jongen-Lavrencic
Seen in:
- Rotterdam, GSK Investigational Site
Trials:
- NCT05424380 (Principal Investigator)
Conditions:
- Leukemia, Myeloid, Acute
P.E. Westerweel
Seen in:
- Dordrecht, NL-Dordrecht-ASZ
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
Petra Muus
Seen in:
- Nijmegen, Radboud University Nijmegen Medical Center
Trials:
- NCT00838240 (Principal Investigator)
Conditions:
- Myelodysplastic Syndromes;
- Leukemia
R.E. Brouwer
Seen in:
- Delft, NL-Delft-RDGG
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
R.S. Boersma
Seen in:
- Breda, NL-Breda-AMPHIA
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2
W.E. Terpstra
Seen in:
- Amsterdam, NL-Amsterdam-OLVG
Trials:
- NCT04027309 (Principal Investigator)
Conditions:
- Acute Myeloid Leukemia;
- Myelodysplastic Syndrome With Excess Blasts-2

Clinical Trials on Myeloid Leukemia

Betta Pharmaceuticals Co., Ltd.

Not yet recruiting

A Study of MRX2843 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia Leukemia

China
Washington University School of Medicine

Withdrawn

Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patents With Refractory or Relapsed AML

Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid Leukemia

United States
C. Babis Andreadis
Gateway for Cancer Research; AVEO Pharmaceuticals, Inc.

Terminated

Ficlatuzumab With High Dose Cytarabine in Relapsed and Refractory AML

Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid Leukemia

United States
Oryzon Genomics S.A.

Recruiting

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+) (FRIDA)

Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory

United States
University Hospital, Antwerp

Recruiting

Treatment With ABT-199 (Venetoclax) and Purine Analogues in Relapsed/Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory

Belgium
Medical College of Wisconsin

Recruiting

Venetoclax to Augment Epigenetic Modification and Chemotherapy

Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory

United States
Massachusetts General Hospital
Exelixis

Completed

Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid Leukemia

United States
Chinese PLA General Hospital

Unknown

Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33 (CART33)

Relapsed Adult Myeloid Leukemia | Chemotherapy Refractory Adult Myeloid Leukemia

China
Peking University People's Hospital
Beijing JD Biotech Co. LTD.

Recruiting

Off-the-shelf CD123 CAR-NK for R/R AML

Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory

China
Xuzhou Medical University

Recruiting

Administration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)

Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory

China

Medical specialists from Netherlands tagged as investigators in clinical trials studying Myeloid Leukemia

Clinical Trials on Myeloid Leukemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations